THERAPEUTIC AREA PORTFOLIO · 3 PRODUCTS
Respiratory & Rare Disease
呼吸与罕见病
The portfolio connects respiratory programs represented by cystic-fibrosis and leukotriene-pathway therapies with selected rare-disease programs present in the product catalog.
Target APIs & Active Pipeline Programs in Respiratory & Rare Disease
ElexacaftorMontelukastSapropterin
Respiratory & Rare Disease Products (3)
Catalog products related to terminal APIs in this area.
H-07CAS 142569-70-8
2-(2-(3-(2-(7-Chloro-2-quinolinyl)-ethenylphenyl)-3-hydroxypropyl)phenyl)-2-propanolTarget API: Montelukast